New ultrasound trick could replace costly scans for common liver tumors
NCT ID NCT07418294
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a new computer-based ultrasound technique called Fluctuational Imaging (FLI) to diagnose hepatic hemangiomas, the most common benign liver tumors. Researchers will enroll 400 adults with liver lesions to see if FLI can reliably tell hemangiomas apart from other growths. If it works, FLI could reduce the need for contrast-enhanced CT or MRI scans, lowering healthcare costs and avoiding radiation or contrast risks.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Fluctuational Imaging (FLI) software algorithm
What this could lead to
If successful, FLI could allow doctors to diagnose liver hemangiomas using only ultrasound, avoiding the need for contrast CT or MRI scans.
What could go wrong
This is an early-stage study with 400 participants, and FLI's accuracy may vary depending on the operator or lesion type. It may not work for all liver lesions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATIC HEMANGIOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Severance hospital, Yonsei university college of medicine
RECRUITINGSeoul, Seodaemun-gu, 03722, South Korea
Contact Phone: •••-•••-•••• Email: •••••@•••••